dsdsa

product

Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

We've got a specialist, effectiveness staff to supply high quality service for our shopper. We always follow the tenet of customer-oriented, details-focused for Ruxolitinib, Liraglutide, Cetilistat, By 10 years effort, we attract customers by competitive price and excellent service. Moreover, it's our honest and sincerity, which help us always be clients' first choice.
Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai Detail:

Product name Entecavir monohydrate
Synonyms 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate
CAS No. 209216-23-9
Appearance White to off-white powder
Molecular Formula C12H15N5O3.H2O
Molecular Weight 295.30
Usage Pharmaceutical Grade or Research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Entecavir monohydrate Cas: 209216-23-9

Items

Standard

Results

Appearance White to off-white powder Complies
Optical rotation +24.0°—+28.0°(DMF:MeOH=1:1 c=1%) +27.0°
Identification A: By IR, To match with working standard Complies
B: By HPLC,retain time should match with working standard Complies
Water 5.8%—6.5% 6.1%
Isomer Single ≤0.1% 0.02%
Total ≤0.5% 0.02%
Related Substances Single impurity ≤0.1% 0.05%
Total impurities ≤0.3% 0.07%
Residue on ignition ≤0.1% 0.04%
Heavy metals £ 10ppm Complies
Residual  solvents Should be to match with the standard Complies
Assay ≥99.8% 99.9%
Conclusion:Complies to the in-house standards.

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures

Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures

Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures


Related Product Guide:

We thinks what clients think, the urgency of urgency to act from the interests of a client position of theory, allowing for greater quality, lessen processing costs, price ranges are much more reasonable, won the new and outdated shoppers the support and affirmation for Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai , The product will supply to all over the world, such as: Oslo, Bogota, Bulgaria, We insist on "Quality First, Reputation First and Customer First". We are committed to providing high-quality products and good after-sales services. Up to now, our products have been exported to more than 60 countries and areas around the world, such as America, Australia and Europe. We enjoy a high reputation at home and abroad. Always persisting in the principle of "Credit, Customer and Quality", we expect cooperation with people in all walks of life for mutual benefits.
  • This is the first business after our company establish, products and services are very satisfying, we have a good start, we hope to cooperate continuous in the future!
    5 Stars By Deborah from Jamaica - 2018.06.05 13:10
    In China, we have many partners, this company is the most satisfying to us, reliable quality and good credit, it is worth appreciation.
    5 Stars By Jack from Florida - 2018.12.05 13:53
    Write your message here and send it to us